Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Oregon: The Definitive Guide for Patients and Families
If you are reading this in Oregon, you have likely moved past the initial shock of a medical complication and are now searching for answers about what happened to your body. Whether you underwent a post-mastectomy reconstruction at a major center in Portland, a cosmetic augmentation in Bend, or a revision surgery in Eugene, the discovery that a medical device may be failing inside you is a traumatic experience. At Attorney911, we recognize that for women and families in Oregon, this journey often involves navigating a complex web of medical systems and legal hurdles. We have built this resource to serve as the comprehensive educational guide you need to understand the science, the regulations, and the legal pathways available to you.
Our managing partner, Ralph Manginello, has spent twenty-seven years advocating for the rights of the injured. Licensed by the State Bar of Texas since 1998 (Bar Card Number 24007597) and admitted to the United States District Court for the Southern District of Texas, he leads a firm dedicated to holding large institutions accountable. We are currently lead counsel in high-profile litigation like Bermudez v. Pi Kappa Phi, seeking $10,000,000 for families impacted by institutional negligence. We bring that same aggressive, high-stakes litigation capability to our work for women in Oregon who have been harmed by defective surgical mesh and acellular dermal matrix (ADM) products.
When a device fails, the consequences are rarely just physical. The financial, emotional, and psychological toll can be overwhelming. If you speak Spanish or feel more comfortable communicating in the language you use at home, our associate attorney, Lupe Peña, conducts full client consultations in fluent Spanish. Her background in insurance defense provides us with an insider’s view of the tactics manufacturers and insurers use to minimize claims. We offer this guide to help you find clarity. If you have questions about your specific situation in Oregon, you can reach us at 1-888-ATTY-911 for a confidential, no-obligation consultation.
Understanding the Devices: Mesh, ADM, and Scaffolds in Oregon Breast Surgery
For many patients in Oregon, the terminology used in surgical reports is a language of its own. To understand your legal options, we must first look at the three primary categories of devices frequently used off-label in breast procedures.
Acellular Dermal Matrix (ADM)
Acellular Dermal Matrix (ADM) describes a biologic “scaffold” derived from either human cadaver skin or animal tissue (porcine or bovine). In Oregon, surgeons often use products like AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), or Strattice (porcine-derived) during reconstruction to support and cover the lower portion of a breast implant. By removing the cells but preserving the structural collagen matrix, these products are intended to integrate into your body.
Bioabsorbable and Resorbable Scaffolds
Bioabsorbable scaffolds are synthetic, man-made materials designed to provide temporary support before being absorbed by the body. The most prominent example is GalaFLEX, manufactured by Galatea Surgical and now owned by Becton Dickinson (BD). Composed of poly-4-hydroxybutyrate (P4HB), these products are marketed to create an “internal bra” for cosmetic mastopexy (breast lift) or reconstruction. However, as we will discuss, the way these materials break down—or fail to break down—within Oregon patients is a central point of litigation.
Synthetic Surgical Mesh
While less common today in breast procedures, permanent synthetic meshes (primarily polypropylene) were sometimes used off-label for reinforcement. These are the same materials that led to massive settlements in pelvic and hernia mesh litigation.
For the woman in Oregon who was never told that these devices were being used in an “off-label” capacity, the realization can be jarring. While surgeons have the right to practice medicine as they see fit, manufacturers like Becton Dickinson and Allergan have a strict legal duty to warn about the risks associated with their products. When they fail to do so, they may be held liable under Oregon’s product liability framework.
The FDA Regulatory Landscape: Why Oregon Patients Were Left at Risk
A common misconception among patients in Portland or Salem is that if a device is in an operating room, it must have been “approved” by the FDA for that specific use. The truth is far more complicated and forms the basis of many defective device claims.
Most breast mesh and ADM products reached the market through the FDA 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a manufacturer does not have to prove a device is safe and effective through clinical trials. Instead, they only need to show it is “substantially equivalent” to a “predicate device.” This has led to what we call “predicate creep,” where a device used in the breast today might trace its legal lineage back to a surgical suture or a hernia mesh used in the abdomen.
The FDA’s own communications have become increasingly clear. On November 9, 2023, the agency issued a letter to health care providers regarding BD mesh products, stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter explicitly named products used throughout Oregon, including GalaFLEX Scaffold, GalaFLEX Lite, and Phasix Mesh.
For Ralph Manginello and our team, this regulatory record is a critical piece of evidence. It demonstrates that the manufacturers knew—or should have known—that their products lacked a determined safety profile for breast tissue. If you or a loved one in Oregon suffered after being implanted with these devices, the law provides a pathway for recovery. Call 1-888-288-9911 today to speak with us about your rights.
The Whistleblower: Dr. Hooman Noorchashm and GalaFLEX Safety
Integrity in the medical device industry is paramount, which is why the whistleblowing of Dr. Hooman Noorchashm is so significant for Oregon plaintiffs. A cardiothoracic surgeon and former Medical Director at Becton Dickinson, Dr. Noorchashm was terminated in 2022 after raising internal alarms about the safety of GalaFLEX.
His allegations, filed in a whistleblower lawsuit under the Conscientious Employee Protection Act, are chilling. He alleges that BD withheld critical data from the FDA regarding breast cancer recurrences in GalaFLEX clinical trials. Furthermore, he claimed that hundreds of Medical Device Reporting (MDR) entries under 21 CFR Part 803 were incomplete or lacked the necessary detail to inform clinicians of the true risks of patient harm.
For a breast cancer survivor in Oregon, the idea that a device manufacturer might hide data about cancer recurrence is the ultimate betrayal. Ralph Manginello and Lupe Peña utilize this whistleblower record to show that the failure to warn was not a mistake—it was a corporate choice.
The Spectrum of Injury: What Oregon Patients Are Facing
The complications associated with defective ADM and scaffolds are not just “side effects”; they are often life-altering medical events. If you have been treated at an Oregon hospital and are experiencing any of the following, you may have a claim:
BIA-ALCL and BIA-SCC (Oncological Risks)
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct T-cell lymphoma recognized by the WHO since 2016. In Oregon, patients with textured implants, particularly Allergan BIOCELL products, have been at elevated risk. The pathology typically shows CD30-positive and ALK-negative cells. Furthermore, the September 2022 FDA Safety Communication warned of Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), an epithelial tumor found in the implant capsule.
Red Breast Syndrome and Endotoxin
Many Oregon patients suffer from “Red Breast Syndrome,” a non-infectious, sterile inflammation specific to ADM implantation. The leading scientific theory is that bacterial endotoxins (LPS) remain on the matrix through the sterilization process, triggering a chronic inflammatory response in the host.
Reconstruction Failure and Sepsis
When an ADM like FlexHD or AlloMax—which were named in the FDA’s March 2021 Safety Communication for elevated complication rates—fails to integrate, it can lead to skin-flap necrosis and deep surgical site infections. These infections can rapidly progress to sepsis, a life-threatening medical emergency.
If you have experienced chronic pain, reconstruction loss, or a cancer diagnosis related to your implants in Oregon, the time to document your evidence is now. Lupe Peña and our staff can help you navigate the process of securing your operative reports and pathology slides. Reach us at 1-888-ATTY-911.
Oregon Product Liability Law: Navigating the Statute of Limitations
When seeking justice in Oregon, understanding the state’s specific legal framework is essential. Oregon’s product liability statutes are found in ORS 30.900 through 30.920.
The Discovery Rule in Oregon
In Oregon, a product liability action for personal injury must generally be filed within two years of the date on which the injury was discovered, or reasonably should have been discovered. This is known as the “discovery rule.” For many women in Portland or Bend, the two-year clock might not have started until they received the November 2023 FDA notification or underwent a revision surgery where the defective nature of the mesh was revealed.
Oregon Statue of Repose
Oregon also has a statute of repose. Generally, an action must be commenced within 10 years of the date the product was first purchased for use or consumption. However, there are exceptions, particularly in cases of fraudulent concealment or when the injury occurs after the repose period but within the product’s useful life.
Non-Economic Damages in Oregon
The Oregon Supreme Court’s 2020 ruling in Busch v. McInnis Waste Systems, Inc. clarified that the $500,000 cap on non-economic damages is unconstitutional as applied to most personal injury actions. This is vital for Oregon patients, as the “pain and suffering” and “permanent disfigurement” associated with breast reconstruction failure are often more significant than the direct medical bills.
Our team, lead by Ralph Manginello, stays at the forefront of these changing state laws to ensure our clients in Oregon receive the maximum compensation allowed. We understand the Oregon judicial system and the federal courts serving the District of Oregon.
The Allergan BIOCELL MDL 2921 and the Path to October 2026
For those in Oregon with textured implants, the most significant legal development is In re Allergan BIOCELL Textured Breast Implant Products Liability Litigation, MDL No. 2921. This multidistrict litigation is centralized before Judge Brian R. Martinotti in the District of New Jersey.
Currently, the court is moving toward “bellwether” trials—test cases that help both sides gauge the value of the claims. Case Management Order No. 37 has set the first surgical-explant bellwether trial for October 19, 2026. The decisions made in that courtroom will directly influence the settlement options for patients across Oregon.
Ralph Manginello and Attorney911 monitor these federal dockets daily. A generalist personal injury firm in Oregon might be aware of the recall, but they may lack the substantive command of the 21 CFR §803 reporting requirements and the Riegel v. Medtronic preemption nuances required to win against billion-dollar defense firms.
Why Experience Matters: The Attorney911 Difference for Oregon
When you call 1-888-ATTY-911, you aren’t just getting a lawyer; you are getting twenty-seven years of continuous practice and a firm with a 4.9 out of 5.0 rating across hundreds of Birdeye reviews. Our managing partner, Ralph Manginello, is a member of the Pro Bono College of the State Bar of Texas, an honor reserved for those who far exceed the aspirational goals for service.
We know that a woman in Oregon facing a BIA-ALCL diagnosis needs more than a settlement; she needs an advocate who understands the CD30+ pathology and the T-cell receptor monoclonality of her case. A woman in the Willamette Valley who has lost her reconstruction to red breast syndrome needs an attorney who knows the difference between an aseptic Sterility Assurance Level (SAL) of 10⁻³ and terminal sterilization.
Lupe Peña’s experience in insurance defense means we know exactly how the manufacturers try to blame the surgeon or the patient’s underlying health for the device failure. In Oregon, we fight to pierce those defenses by focusing on the manufacturer’s failure to warn and the deceptive off-label promotion documented by whistleblowers like Dr. Noorchashm.
Steps to Take If You Suspect a Device Injury in Oregon
If you are in Oregon and believe your surgical mesh, ADM, or scaffold is failing, we recommend the following protocol to protect your health and your legal rights:
- Seek Medical Consultation: Contact your surgeon or a specialist at a major academic center in Portland or your regional hub. Request an MRI or ultrasound to check for seroma or malposition.
- Request Your Operative Report: Under Oregon law, you have a right to your medical records. Explicitly ask for the “Operative Note” and the “Implant Log” or “Sticker Page.” These contain the lot numbers and Unique Device Identifiers (UDI) needed to identify the manufacturer.
- Document Symptoms: Take photographs of visible redness, swelling, or asymmetry. Keep a journal of your pain levels and any systemic symptoms like fatigue or joint pain often associated with breast implant illness.
- Preserve Evidence: If you undergo revision surgery and the mesh or scaffold is removed, ensure your surgeon and the pathology lab know to preserve the explanted material. It is your property and critical evidence.
- Speak with Counsel: Before signing any “compensation” or “release” forms from a manufacturer, consult with an experienced product liability attorney.
Frequently Asked Questions for Oregon Patients
Is surgical mesh approved by the FDA for breast surgery?
No. As the FDA stated in November 2023, the safety and effectiveness of surgical mesh in breast surgery has not been determined by the agency. No surgical mesh product currently carries specific FDA clearance for breast reconstruction or augmentation.
What is the statute of limitations in Oregon?
Generally, you have two years from the point of discovery to file suit in Oregon. However, every case is unique, and you should speak with Ralph Manginello or our team to determine the specific deadline for your circumstances.
Can I sue if I have not been diagnosed with cancer?
Yes. Complications like chronic pain, red breast syndrome, and reconstruction failure are serious injuries. The litigation against manufacturers like Becton Dickinson addresses a wide range of physical and financial harms, not just BIA-ALCL.
How do I know which brand was used?
Your Oregon hospital’s operative report will contain a sticker page with the brand (e.g., GalaFLEX, AlloDerm, Strattice) and lot number. We can assist you in obtaining these records if the hospital is being uncooperative.
What does it cost to hire Attorney911?
We work on a contingency fee basis. This means there is no upfront cost to you. We only get paid if we recover compensation for you. We assume the financial risk of the litigation so you can focus on your recovery.
Hablamos español?
Sí. Lupe Peña realiza consultas completas en español para asegurar que nuestras clientes en Oregon reciban la mejor representación posible sin barreras lingüísticas.
A Commitment to Oregon Survivors and Their Families
The path following a major surgical complication is difficult. Many women feel a sense of isolation or even self-blame, but the evidence shows that the failure of these devices is often rooted in systemic regulatory gaps and corporate negligence. At Attorney911, we are the firm that takes on the tough cases—the ones involving complex medical institutions and multi-defendant litigations, as seen in our work on the Bermudez case.
Whether you are a breast cancer survivor in Portland who has lost the symmetry you fought so hard for, or a patient in Southern Oregon dealing with the systemic symptoms of breast implant illness, your case matters to us. We serve as a bridge between the clinical reality of your injury and the legal requirements of a winning product liability claim.
Ralph Manginello’s twenty-seven years of experience, combined with Lupe Peña’s bilingual advocacy and insurance-defense background, makes us the clear choice for Oregon residents seeking justice. We are honored to serve the communities of Oregon, from the coastal counties to the eastern plateaus.
Reach Out Today
Do not let a statute of limitations in Oregon expire while you wait for a manufacturer to “make things right.” They have teams of defense lawyers working to protect their bottom line; you deserve a team that is dedicated to yours.
Call 1-888-ATTY-911 (1-888-288-9911) today for a free, confidential consultation. Our offices are ready to listen, and our attorneys are ready to fight for the compensation you need to cover medical bills, lost wages, and the pain you have endured. When you are ready to talk about what happened to you in Oregon, we are here to help.
Disclaimer: This content is for educational purposes and does not constitute medical advice or an attorney-client relationship. The Manginello Law Firm, PLLC (Attorney911) is a Texas-based firm with federal court admissions and the capability to handle complex device litigation nationwide. Past results do not guarantee future outcomes. Contact our office for a specific evaluation of your Oregon case.
